HSGFX vs. BIVIX
Compare and contrast key facts about Hussman Strategic Growth Fund (HSGFX) and Invenomic Fund Institutional Class (BIVIX).
HSGFX is managed by Hussman Funds. It was launched on Jul 24, 2000. BIVIX is an actively managed fund by Invenomic. It was launched on Jun 19, 2017.
Performance
HSGFX vs. BIVIX - Performance Comparison
Loading graphics...
HSGFX vs. BIVIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HSGFX Hussman Strategic Growth Fund | 5.80% | 6.24% | -6.99% | -11.60% | 17.33% | -0.23% | 14.52% | -18.87% | 8.78% | -5.39% |
BIVIX Invenomic Fund Institutional Class | 6.05% | 4.63% | -8.81% | 16.80% | 50.01% | 63.81% | 11.46% | 11.59% | 3.68% | 8.93% |
Returns By Period
The year-to-date returns for both investments are quite close, with HSGFX having a 5.80% return and BIVIX slightly higher at 6.05%.
HSGFX
- 1D
- -0.17%
- 1M
- 5.24%
- YTD
- 5.80%
- 6M
- 2.66%
- 1Y
- 0.49%
- 3Y*
- -1.32%
- 5Y*
- -0.64%
- 10Y*
- -1.69%
BIVIX
- 1D
- 3.47%
- 1M
- 2.62%
- YTD
- 6.05%
- 6M
- 11.34%
- 1Y
- 7.17%
- 3Y*
- 1.96%
- 5Y*
- 17.01%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
HSGFX vs. BIVIX - Expense Ratio Comparison
HSGFX has a 1.15% expense ratio, which is lower than BIVIX's 3.17% expense ratio.
Return for Risk
HSGFX vs. BIVIX — Risk / Return Rank
HSGFX
BIVIX
HSGFX vs. BIVIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hussman Strategic Growth Fund (HSGFX) and Invenomic Fund Institutional Class (BIVIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HSGFX | BIVIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.09 | 0.33 | -0.24 |
Sortino ratioReturn per unit of downside risk | 0.25 | 0.67 | -0.42 |
Omega ratioGain probability vs. loss probability | 1.03 | 1.07 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 0.14 | 0.44 | -0.30 |
Martin ratioReturn relative to average drawdown | 0.22 | 0.99 | -0.78 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| HSGFX | BIVIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.09 | 0.33 | -0.24 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.06 | 1.07 | -1.12 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.16 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.07 | 1.05 | -0.98 |
Correlation
The correlation between HSGFX and BIVIX is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
HSGFX vs. BIVIX - Dividend Comparison
HSGFX's dividend yield for the trailing twelve months is around 2.20%, more than BIVIX's 2.07% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HSGFX Hussman Strategic Growth Fund | 2.20% | 2.33% | 3.00% | 3.10% | 1.08% | 0.42% | 0.16% | 1.84% | 1.19% | 0.50% | 0.28% | 0.56% |
BIVIX Invenomic Fund Institutional Class | 2.07% | 2.20% | 3.95% | 20.15% | 27.91% | 16.08% | 3.15% | 3.19% | 4.79% | 1.21% | 0.00% | 0.00% |
Drawdowns
HSGFX vs. BIVIX - Drawdown Comparison
The maximum HSGFX drawdown since its inception was -60.61%, which is greater than BIVIX's maximum drawdown of -18.32%. Use the drawdown chart below to compare losses from any high point for HSGFX and BIVIX.
Loading graphics...
Drawdown Indicators
| HSGFX | BIVIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.61% | -18.32% | -42.29% |
Max Drawdown (1Y)Largest decline over 1 year | -18.73% | -13.71% | -5.02% |
Max Drawdown (5Y)Largest decline over 5 years | -22.42% | -17.23% | -5.19% |
Max Drawdown (10Y)Largest decline over 10 years | -34.70% | — | — |
Current DrawdownCurrent decline from peak | -49.60% | -0.64% | -48.96% |
Average DrawdownAverage peak-to-trough decline | -26.67% | -5.75% | -20.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.35% | 6.10% | +6.25% |
Volatility
HSGFX vs. BIVIX - Volatility Comparison
The current volatility for Hussman Strategic Growth Fund (HSGFX) is 3.93%, while Invenomic Fund Institutional Class (BIVIX) has a volatility of 7.63%. This indicates that HSGFX experiences smaller price fluctuations and is considered to be less risky than BIVIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| HSGFX | BIVIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.93% | 7.63% | -3.70% |
Volatility (6M)Calculated over the trailing 6-month period | 8.42% | 16.63% | -8.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 12.48% | 20.71% | -8.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 10.93% | 16.09% | -5.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 10.59% | 16.60% | -6.01% |